Biology:Beta-2 adrenergic receptor
Generic protein structure example |
The beta-2 adrenergic receptor (β2 adrenoreceptor), also known as ADRB2, is a cell membrane-spanning beta-adrenergic receptor that binds epinephrine (adrenaline), a hormone and neurotransmitter whose signaling, via adenylate cyclase stimulation through trimeric Gs proteins, increases cAMP, and, via downstream L-type calcium channel interaction, mediates physiologic responses such as smooth muscle relaxation and bronchodilation.[1]
Robert J. Lefkowitz[2] and Brian Kobilka[3] studied beta 2 adrenergic receptor as a model system which rewarded them the 2012 Nobel Prize in Chemistry[4] “for groundbreaking discoveries that reveal the inner workings of an important family of such receptors: G-protein-coupled-receptors”.
The official symbol for the human gene encoding the β2 adrenoreceptor is ADRB2.[5]
Gene
The ADRB2 gene is intronless. Different polymorphic forms, point mutations, and/or downregulation of this gene are associated with nocturnal asthma, obesity and type 2 diabetes.[6]
Structure
The 3D crystallographic structure (see figure and links to the right) of the β2-adrenergic receptor has been determined[7][8][9] by making a fusion protein with lysozyme to increase the hydrophilic surface area of the protein for crystal contacts. An alternative method, involving production of a fusion protein with an agonist, supported lipid-bilayer co-crystallization and generation of a 3.5 Å resolution structure.[10]
The crystal structure of the β2Adrenergic Receptor-Gs protein complex was solved in 2011. The largest conformational changes in the β2AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an alpha helical extension of the cytoplasmic end of TM5.[11]
Mechanism
This receptor is directly associated with one of its ultimate effectors, the class C L-type calcium channel CaV1.2.[citation needed] This receptor-channel complex is coupled to the Gs G protein, which activates adenylyl cyclase, catalysing the formation of cyclic adenosine monophosphate (cAMP) which then activates protein kinase A, and counterbalancing phosphatase PP2A. Protein kinase A then goes on to phosphorylate (and thus inactivate) myosin light-chain kinase, which causes smooth muscle relaxation, accounting for the vasodilatory effects of beta 2 stimulation. The assembly of the signaling complex provides a mechanism that ensures specific and rapid signaling. A two-state biophysical and molecular model has been proposed to account for the pH and REDOX sensitivity of this and other GPCRs.[12]
Beta-2 adrenergic receptors have also been found to couple with Gi, possibly providing a mechanism by which response to ligand is highly localized within cells. In contrast, Beta-1 adrenergic receptors are coupled only to Gs, and stimulation of these results in a more diffuse cellular response.[13] This appears to be mediated by cAMP induced PKA phosphorylation of the receptor.[14] Interestingly, Beta-2 adrenergic receptor was observed to localize exclusively to the T-tubular network of adult cardiomyocytes, as opposed to Beta-1 adrenergic receptor, which is observed also on the outer plasma membrane of the cell [15]
Function
Function | Tissue | Biological Role |
---|---|---|
Smooth muscle relaxation in: | GI tract (decreases motility) | Inhibition of digestion |
Bronchi[16] | Facilitation of respiration. | |
Detrusor urinae muscle of bladder wall[17][18] This effect is stronger than the alpha-1 receptor effect of contraction. | Inhibition of need for micturition | |
Uterus | Inhibition of labor | |
Seminal tract[19] | ||
Increased perfusion and vasodilation | Blood vessels and arteries to skeletal muscle including the smaller coronary arteries[20] and hepatic artery | Facilitation of muscle contraction and motility |
Increased mass and contraction speed | Striated muscle[19] | |
Insulin and glucagon secretion | Pancreas[21] | Increased blood glucose and uptake by skeletal muscle |
Glycogenolysis[19] | ||
Tremor | Motor nerve terminals.[19] Tremor is mediated by PKA mediated facilitation of presynaptic Ca2+ influx leading to acetylcholine release. |
Legend
The function facilitates the fight-or-flight response.
|
Musculoskeletal system
Activation of the β2 adrenoreceptor with long-acting agents such as oral clenbuterol and intravenously-infused albuterol results in skeletomuscular hypertrophy and anabolism.[22][23] The comprehensive anabolic, lipolytic, and ergogenic effects of long-acting β2 agonists such as clenbuterol render them frequent targets as performance-enhancing drugs in athletes.[24] Consequently, such agents are monitored for and generally banned by WADA (World Anti-Doping Agency) with limited permissible usage under therapeutic exemptions; clenbuterol and other β2 adrenergic agents remain banned not as a beta-agonist, but rather an anabolic agent. These effects are largely attractive within agricultural contexts insofar that β2 adrenergic agents have seen notable extra-label usage in food-producing animals and livestock. While many countries including the United States have prohibited extra-label usage in food-producing livestock, the practice is still observed in many countries. [25][26]
Circulatory system
- Heart muscle contraction
- Increase cardiac output (minor degree compared to β1).
- Increases heart rate[16] in sinoatrial node (SA node) (chronotropic effect).
- Increases atrial cardiac muscle contractility. (inotropic effect).
- Increases contractility and automaticity[16] of ventricular cardiac muscle.
- Dilate hepatic artery.
- Dilate arterioles to skeletal muscle.
Eye
In the normal eye, beta-2 stimulation by salbutamol increases intraocular pressure via net:
- Increase in production of aqueous humour by the ciliary process,
- Subsequent increased pressure-dependent uveoscleral outflow of humour, despite reduced drainage of humour via the Canal of Schlemm.
In glaucoma, drainage is reduced (open-angle glaucoma) or blocked completely (closed-angle glaucoma). In such cases, beta-2 stimulation with its consequent increase in humour production is highly contra-indicated, and conversely, a topical beta-2 antagonist such as timolol may be employed.
Digestive system
- Glycogenolysis and gluconeogenesis in liver.[16]
- Glycogenolysis and lactate release in skeletal muscle.[16]
- Contract sphincters of Gastrointestinal tract.
- Thickened secretions from salivary glands.[16]
- Insulin and glucagon secretion from pancreas.[21]
Other
- Inhibit histamine-release from mast cells.
- Increase protein content of secretions from lacrimal glands.
- Receptor also present in cerebellum.
- Bronchiole dilation (targeted while treating asthma attacks)
- Involved in brain - immune - communication [27]
Ligands
Agonists
Spasmolytics used in asthma and COPD
- Short-acting β2 agonists (SABA)
- bitolterol
- fenoterol
- hexoprenaline
- isoprenaline (INN) or isoproterenol (USAN)
- levosalbutamol (INN) or levalbuterol (USAN)
- orciprenaline (INN) or metaproterenol (USAN)
- pirbuterol
- procaterol
- salbutamol (INN) or albuterol (USAN)
- terbutaline
- Long-acting β2 agonists (LABA)
- arformoterol (some consider it to be an ultra-LABA)[28]
- bambuterol
- clenbuterol
- formoterol
- salmeterol
- Ultra-long-acting β2 agonists (ultra-LABA)
- carmoterol
- indacaterol
- milveterol (GSK 159797)
- olodaterol
- vilanterol (GSK 642444)
Tocolytic agents
- Short-acting β2 agonists (SABA)
- fenoterol
- hexoprenaline
- isoxsuprine
- ritodrine
- salbutamol (INN) or albuterol (USAN)
- terbutaline
β2 agonists used for other purposes
Antagonists
* denotes selective antagonist to the receptor.
Allosteric modulators
- compound-6FA,[29] PAM at intracellular binding site
Interactions
Beta-2 adrenergic receptor has been shown to interact with:
See also
- Other adrenergic receptors
- Discovery and development of beta2 agonists
References
- ↑ "Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation". The Journal of Allergy and Clinical Immunology 117 (1): 18–24; quiz 25. January 2006. doi:10.1016/j.jaci.2005.11.012. PMID 16387578.
- ↑ "The Nobel Prize in Chemistry 2012" (in en-US). https://www.nobelprize.org/prizes/chemistry/2012/lefkowitz/facts/.
- ↑ "The Nobel Prize in Chemistry 2012" (in en-US). https://www.nobelprize.org/prizes/chemistry/2012/kobilka/facts/.
- ↑ "The Nobel Prize in Chemistry 2012" (in en-US). https://www.nobelprize.org/prizes/chemistry/2012/summary/.
- ↑ "Entrez Gene: ADRB2 adrenoceptor beta 2, surface". https://www.ncbi.nlm.nih.gov/gene/154.
- ↑ "Entrez Gene: ADRB2 adrenergic, beta-2-, receptor, surface". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=154.
- ↑ "High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor". Science 318 (5854): 1258–65. 2007. doi:10.1126/science.1150577. PMID 17962520. Bibcode: 2007Sci...318.1258C.
- ↑ "GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function". Science 318 (5854): 1266–73. 2007. doi:10.1126/science.1150609. PMID 17962519. Bibcode: 2007Sci...318.1266R.
- ↑ "Crystal structure of the human beta2 adrenergic G-protein-coupled receptor". Nature 450 (7168): 383–7. Nov 2007. doi:10.1038/nature06325. PMID 17952055. Bibcode: 2007Natur.450..383R.
- ↑ "Dissecting the Structure of Membrane Proteins". Genetic Engineering & Biotechnology News 35 (17): 16. 1 October 2015. doi:10.1089/gen.35.07.09. http://www.genengnews.com/gen-articles/dissecting-the-structure-of-membrane-proteins/5583/.(Subscription content?)
- ↑ "Crystal structure of the β2 adrenergic receptor-Gs protein complex". Nature 477 (7366): 549–55. July 2011. doi:10.1038/nature10361. PMID 21772288. Bibcode: 2011Natur.477..549R.
- ↑ "Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation". Journal of Molecular Graphics & Modelling 25 (4): 396–409. Dec 2006. doi:10.1016/j.jmgm.2006.02.008. PMID 16574446.
- ↑ "G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels". Biophysical Journal 79 (5): 2547–56. Nov 2000. doi:10.1016/S0006-3495(00)76495-2. PMID 11053129. Bibcode: 2000BpJ....79.2547C.
- ↑ "Protein kinase A-mediated phosphorylation of the beta 2-adrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system". The Journal of Biological Chemistry 277 (34): 31249–56. Aug 2002. doi:10.1074/jbc.M202753200. PMID 12063255.
- ↑ "Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes". Proceedings of the National Academy of Sciences of the United States of America 118 (23): e2101119118. June 2021. doi:10.1073/pnas.2101119118. ISSN 0027-8424. PMID 34088840.
- ↑ 16.0 16.1 16.2 16.3 16.4 16.5 "Table 20:2". Neuroscience (Third ed.). Sunderland, Mass: Sinauer. 2004. ISBN 978-0-87893-725-7.
- ↑ "Response of guinea pig smooth and striated urethral sphincter to cromakalim, prazosin, nifedipine, nitroprusside, and electrical stimulation". Neurourology and Urodynamics 14 (2): 153–68. 1995. doi:10.1002/nau.1930140208. PMID 7540086.
- ↑ "Adrenoceptor function and expression in bladder urothelium and lamina propria". Urology 81 (1): 211.e1–7. January 2013. doi:10.1016/j.urology.2012.09.011. PMID 23200975.
- ↑ 19.0 19.1 19.2 19.3 19.4 Pharmacology. Edinburgh: Churchill Livingstone. 2003. ISBN 978-0-443-07145-4. Page 163
- ↑ Pharmacology. Edinburgh: Churchill Livingstone. 2003. p. 270. ISBN 978-0-443-07145-4.
- ↑ 21.0 21.1 "beta-Agonists and metabolism". The Journal of Allergy and Clinical Immunology 110 (6 Suppl): S313-7. December 2002. doi:10.1067/mai.2002.129702. PMID 12464941.
- ↑ "Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation". The American Journal of Physiology 263 (1 Pt 1): E50-6. July 1992. doi:10.1152/ajpendo.1992.263.1.E50. PMID 1322047.
- ↑ "Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure". The Journal of Heart and Lung Transplantation 27 (4): 457–61. April 2008. doi:10.1016/j.healun.2008.01.013. PMID 18374884.
- ↑ "The rush to adrenaline: drugs in sport acting on the beta-adrenergic system". British Journal of Pharmacology 154 (3): 584–97. June 2008. doi:10.1038/bjp.2008.164. PMID 18500380.
- ↑ "Clenbuterol". Drug Enforcement Agency. https://www.deadiversion.usdoj.gov/drug_chem_info/clenbuterol.pdf.
- ↑ "Food and Drugs - ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS". U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=530.41.
- ↑ "The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system". Pharmacological Reviews 52 (4): 595–638. Dec 2000. PMID 11121511.
- ↑ "ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?". Drugs 67 (4): 503–15. 2007. doi:10.2165/00003495-200767040-00002. PMID 17352511.
- ↑ "Mechanism of β2AR regulation by an intracellular positive allosteric modulator". Science 364 (6447): 1283–1287. June 2019. doi:10.1126/science.aaw8981. PMID 31249059. Bibcode: 2019Sci...364.1283L.
- ↑ "The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the beta 2-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization". The Journal of Biological Chemistry 276 (26): 24005–14. Jun 2001. doi:10.1074/jbc.M011199200. PMID 11309381.
- ↑ "Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin". The Journal of Biological Chemistry 274 (3): 1588–95. Jan 1999. doi:10.1074/jbc.274.3.1588. PMID 9880537.
- ↑ "Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human delta -opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy". The Journal of Biological Chemistry 276 (17): 14092–9. Apr 2001. doi:10.1074/jbc.M008902200. PMID 11278447.
- ↑ "Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350". The Journal of Biological Chemistry 273 (49): 33035–41. Dec 1998. doi:10.1074/jbc.273.49.33035. PMID 9830057.
- ↑ "SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors". Nature Cell Biology 13 (6): 715–21. Jun 2011. doi:10.1038/ncb2252. PMID 21602791.
- ↑ "Structural determinants of the Na+/H+ exchanger regulatory factor interaction with the beta 2 adrenergic and platelet-derived growth factor receptors". The Journal of Biological Chemistry 277 (21): 18973–8. May 2002. doi:10.1074/jbc.M201507200. PMID 11882663.
- ↑ "A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins". Proceedings of the National Academy of Sciences of the United States of America 95 (15): 8496–501. Jul 1998. doi:10.1073/pnas.95.15.8496. PMID 9671706. Bibcode: 1998PNAS...95.8496H.
- ↑ "The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange". Nature 392 (6676): 626–30. Apr 1998. doi:10.1038/33458. PMID 9560162. Bibcode: 1998Natur.392..626H.
Further reading
- "Properties of the beta 1- and beta 2-adrenergic receptor subtypes revealed by molecular cloning". Clinical Chemistry 35 (5): 721–5. May 1989. doi:10.1093/clinchem/35.5.721. PMID 2541947.
- "Genetic variation of the beta(2)-adrenoceptor: its functional and clinical importance in bronchial asthma". American Journal of Pharmacogenomics 1 (3): 165–74. 2002. doi:10.2165/00129785-200101030-00002. PMID 12083965.
- "Chapter 14 Molecular pharmacology and modeling of vasopressin receptors". Vasopressin and Oxytocin: From Genes to Clinical Applications. Progress in Brain Research. 139. 2002. pp. 179–96. doi:10.1016/S0079-6123(02)39016-2. ISBN 9780444509826.
- "beta2-Adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese". Annals of Human Genetics 69 (Pt 1): 36–44. Jan 2005. doi:10.1046/j.1529-8817.2003.00093.x. PMID 15638826.
- "Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9". Clinical Pharmacology and Therapeutics 82 (2): 215–8. Aug 2007. doi:10.1038/sj.clpt.6100142. PMID 17329986.
- "Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors". The Journal of Biological Chemistry 267 (5): 3530–8. Feb 1992. doi:10.1016/S0021-9258(19)50762-1. PMID 1371121.
- "Genetic changes at the beta-2-adrenergic receptor locus on chromosome 5 in human colorectal carcinomas". Anticancer Research 11 (6): 2047–50. 1992. PMID 1663718.
- "Phorbol-ester-induced phosphorylation of the beta 2-adrenergic receptor decreases its coupling to Gs". FEBS Letters 279 (2): 243–8. Feb 1991. doi:10.1016/0014-5793(91)80159-Z. PMID 1848190.
- "Chromosomal organization of adrenergic receptor genes". Proceedings of the National Academy of Sciences of the United States of America 87 (4): 1516–20. Feb 1990. doi:10.1073/pnas.87.4.1516. PMID 2154750. Bibcode: 1990PNAS...87.1516Y.
- "Effects of protein kinase inhibitor, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, on beta-2 adrenergic receptor activation and desensitization in intact human lymphocytes". The Journal of Pharmacology and Experimental Therapeutics 249 (2): 492–8. May 1989. PMID 2470898.
- "Activation of the beta 2-adrenergic receptor promotes growth and differentiation in thyroid cells". Proceedings of the National Academy of Sciences of the United States of America 86 (12): 4785–8. Jun 1989. doi:10.1073/pnas.86.12.4785. PMID 2471981. Bibcode: 1989PNAS...86.4785H.
- "Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor". The Journal of Biological Chemistry 264 (13): 7564–9. May 1989. doi:10.1016/S0021-9258(18)83271-9. PMID 2540197.
- "Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium". Molecular Pharmacology 35 (3): 295–303. Mar 1989. PMID 2564629.
- "Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization". Proceedings of the National Academy of Sciences of the United States of America 84 (20): 6995–9. Oct 1987. doi:10.1073/pnas.84.20.6995. PMID 2823249. Bibcode: 1987PNAS...84.6995E.
- "Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation". The Journal of Biological Chemistry 263 (9): 4052–5. Mar 1988. doi:10.1016/S0021-9258(18)68888-X. PMID 2831218.
- "Dephosphorylation of the beta 2-adrenergic receptor and rhodopsin by latent phosphatase 2". The Journal of Biological Chemistry 263 (18): 8856–8. Jun 1988. doi:10.1016/S0021-9258(18)68386-3. PMID 2837466.
- "cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor". Proceedings of the National Academy of Sciences of the United States of America 84 (1): 46–50. Jan 1987. doi:10.1073/pnas.84.1.46. PMID 3025863. Bibcode: 1987PNAS...84...46K.
- "Cloning and sequence analysis of the human brain beta-adrenergic receptor. Evolutionary relationship to rodent and avian beta-receptors and porcine muscarinic receptors". FEBS Letters 211 (2): 200–6. Jan 1987. doi:10.1016/0014-5793(87)81436-9. PMID 3026848.
External links
- "β2-adrenoceptor". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. http://www.iuphar-db.org/GPCR/ReceptorDisplayForward?receptorID=2189.
- Human ADRB2 genome location and ADRB2 gene details page in the UCSC Genome Browser.
- Overview of all the structural information available in the PDB for UniProt: P07550 ( Beta-2 adrenergic receptor) at the PDBe-KB.
Original source: https://en.wikipedia.org/wiki/Beta-2 adrenergic receptor.
Read more |